234 related articles for article (PubMed ID: 18992746)
1. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.
Nobili V; Parkes J; Bottazzo G; Marcellini M; Cross R; Newman D; Vizzutti F; Pinzani M; Rosenberg WM
Gastroenterology; 2009 Jan; 136(1):160-7. PubMed ID: 18992746
[TBL] [Abstract][Full Text] [Related]
2. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wierzbicka A; Socha P; Pronicki M; Skiba E; Werpachowska I; Kaczmarski M
Acta Biochim Pol; 2011; 58(4):563-6. PubMed ID: 22140659
[TBL] [Abstract][Full Text] [Related]
4. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.
Polyzos SA; Slavakis A; Koumerkeridis G; Katsinelos P; Kountouras J
Horm Metab Res; 2019 Feb; 51(2):134-140. PubMed ID: 30273934
[TBL] [Abstract][Full Text] [Related]
6. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Loomba R; Jain A; Diehl AM; Guy CD; Portenier D; Sudan R; Singh S; Faulkner C; Richards L; Hester KD; Okada L; Li XJ; Mimms L; Abdelmalek MF
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1867-1876.e3. PubMed ID: 30448594
[TBL] [Abstract][Full Text] [Related]
7. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
[TBL] [Abstract][Full Text] [Related]
8. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.
Younossi ZM; Page S; Rafiq N; Birerdinc A; Stepanova M; Hossain N; Afendy A; Younoszai Z; Goodman Z; Baranova A
Obes Surg; 2011 Apr; 21(4):431-9. PubMed ID: 20532833
[TBL] [Abstract][Full Text] [Related]
9. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis.
Vali Y; Lee J; Boursier J; Spijker R; Löffler J; Verheij J; Brosnan MJ; Böcskei Z; Anstee QM; Bossuyt PM; Zafarmand MH;
J Hepatol; 2020 Aug; 73(2):252-262. PubMed ID: 32275982
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
[TBL] [Abstract][Full Text] [Related]
11. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients.
Omran D; Yosry A; Darweesh SK; Nabeel MM; El-Beshlawey M; Saif S; Fared A; Hassany M; Zayed RA
Clin Exp Med; 2018 Feb; 18(1):45-50. PubMed ID: 28567544
[TBL] [Abstract][Full Text] [Related]
12. Analytical performance of the Enhanced Liver Fibrosis (ELF) Test on the Atellica IM Analyzer.
Palladino A; Gee M; Shalhoub V; Kiaei D
Clin Chim Acta; 2023 Aug; 548():117461. PubMed ID: 37390944
[TBL] [Abstract][Full Text] [Related]
13. Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease.
Mosca A; Comparcola D; Romito I; Mantovani A; Nobili V; Byrne CD; Alisi A; Targher G
Liver Int; 2019 Dec; 39(12):2317-2329. PubMed ID: 31436362
[TBL] [Abstract][Full Text] [Related]
14. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis.
Alkhouri N; Carter-Kent C; Lopez R; Rosenberg WM; Pinzani M; Bedogni G; Feldstein AE; Nobili V
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):150-5. PubMed ID: 20888433
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin.
Gawrieh S; Harlow KE; Pike F; Yates KP; Wilson LA; Cummings OW; Rosenberg WM; Chalasani N; Molleston JP
J Pediatr; 2021 Dec; 239():161-167.e5. PubMed ID: 34400208
[TBL] [Abstract][Full Text] [Related]
16. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V
Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
[TBL] [Abstract][Full Text] [Related]
17. Systematic review: Accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosis.
Sharma C; Cococcia S; Ellis N; Parkes J; Rosenberg W
J Gastroenterol Hepatol; 2021 Jul; 36(7):1788-1802. PubMed ID: 33668077
[TBL] [Abstract][Full Text] [Related]
18. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.
Valva P; Casciato P; Diaz Carrasco JM; Gadano A; Galdame O; Galoppo MC; Mullen E; De Matteo E; Preciado MV
PLoS One; 2011; 6(8):e23218. PubMed ID: 21858035
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
Kaneda H; Hashimoto E; Yatsuji S; Tokushige K; Shiratori K
J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of the specialised blood fibrosis tests FibroMeter
Guillaume M; Moal V; Delabaudiere C; Zuberbuhler F; Robic MA; Lannes A; Metivier S; Oberti F; Gourdy P; Fouchard-Hubert I; Selves J; Michalak S; Peron JM; Cales P; Bureau C; Boursier J
Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1214-1222. PubMed ID: 31617224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
